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Summary 
The superior resistance of some strains of mice over others to infection with certain intraceUu- 
lar pathogens,  including  the  vaccine  strain  of Mycobacterium bovis, bacillus  Calmette  Guerin 
(BCG), is determined by a gene associated with a small segment of chromosome 1 designated 
the Ity/Lsh/Bcg locus, referred to here as the Bcg locus. DBA/2 mice containing the dominant 
resistant allele of the Bcg gene (Bcg'), major histocompatibility complex-compatible BALB/c 
mice containing the recessive susceptible allele (Bcg~), and congenic C.D2-N20 Bcg', which are 
genetically the same as BALB/c mice except for possessing a small piece of DBA/2 chromo- 
some 1 containing the Bcg locus, were used to determine whether the Bcg gene determines re- 
sistance to infection with the virulent H37P,.v strain of Mycobacterium tuberculosis (Mtb). Accord- 
ing to the survival times of Bcg" and B~ mice infected via either the intravenous or respiratory 
route, Bcg" mice proved much less, rather than more, resistant to Mtb infection than Bcg' mice. 
Shorter survival times of Bcg' mice were associated with an inferior capacity to control Mtb 
growth in their lungs and to retard the development of Mtb-induced pathology in this organ. 
Resistance to Mtb infection was a dominant trait in the F1 progeny of Bc,~ and Bcg  ~  mice. The 
results show that resistance to Mtb is not determined by the resistance allele of the Bcg gene nor 
by the recently isolated candidate Bcg gene Nrampl, located in the Bcg locus. 
S 
ome strains of mice show a higher level of natural resis- 
tance  than  others  to  infection  with  certain pathogens, 
including  Salmonella typhimurium,  Leishmania donovani, and 
the  attenuated  bacillus  Calmette  Guerin  (BCG)  ~ strain  of 
Mycobacterium bovis (1). The genes responsible for resistance 
to each of these three pathogens have been mapped inde- 
pendently to  a  small region  of chromosome  1  designated 
the Ity/Lsh/Bcg locus (2--4), and referred to here as the Bcg 
locus.  It is  generally believed that  resistance  to  all  of the 
pathogens mentioned is under the control of a single dom- 
inant gene. According to a number of studies,  the gene is 
expressed in macrophages (5-7), and its dominant resistant 
allele provides  these  cells  with  a  superior innate  capacity 
to kill  microbial  pathogens  or  restrict  their  intraceUular 
growth before the generation of specific host immunity. 
A knowledge of the genetic and physical intervals defin- 
ing  the  Bcg locus  of mouse  chromosome  1  was  used  re- 
cently to identify several candidate transcriptional units for 
the Bcg gene,  one of which was choses as the most likely 
candidate gene because it is expressed exclusively in mac- 
rophages. This candidate gene, designated Nramp I  (for nat- 
1Abbreviations used in this paper: BCG, bacillus Calmette Guerin; MST, 
median survival  time; Mtb, Mycobacterium  tuberculosis;  Nramp, natural resis- 
tance-associated macrophage  protein. 
ural resistance-associated macrophage protein), encodes for 
a polypeptide that is part of the transmembrane domain of a 
macrophage-specific  membrane  protein  (8).  Additional 
studies with a variety ofBCG-resistant (Bcg') and -suscepti- 
ble (Bcg  ~) strains of mice showed anti-BCG resistance to be 
associated with a nonconservative Gly-169-to-Asp-169 sub- 
stitution within the predicted transmembrane domain 4  of 
Nrampl  (9-11).  More  recently,  targeting  of the  Nrampl 
gene by homologous recombination was used to generate 
mutant mice bearing a  null-resistant  allele of the Nrampl 
gene (11).  These mice proved to be susceptible to BCG, S. 
typhimurium, and L. donovani. An homologous gene has been 
shown to be expressed in human macrophages (12), thereby 
opening the way to investigating whether sequence varia- 
tions in this gene are associated with differences in suscepti- 
bility  to  tuberculosis  among families in  endemic  areas  of 
the  disease.  Even so,  it needs  to be remembered that,  in 
spite of the  evidence that Nrampl  is  the  gene that deter- 
mines innate resistance of mice to BCG infection, there is 
litde evidence that this gene is responsible for determining 
resistance to infection with virulent strains of Mycobacterium 
tuberculosis (Mtb). 
The purpose of this article is to show, with MHC-com- 
patible Bcg" and Bcg  ~ strains of mice, and with a  congenic 
Bcg" strain,  that the Bcg gene appears to be of litde impor- 
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lent H37Rv strain of Mtb. 
Materials and Methods 
Animals.  Inbred,  pathogen-free,  8-wk-old  BALB/c  (Bcg~), 
DBA/2 (Bcgg, and CD2F1  (BALB/c ￿  DBA/2) mice were pur- 
chased from Trudeau  Institute Animal Breeding Facility. Con- 
genic C.D2 Idhb-Ityr-Pep3b (C.D2-N20) Bcg'  breeder mice were 
kindly provided by Dr. Emil Skamene of the Montreal General 
Hospital Research Institute (Montreal, Quebec,  Canada). These 
mice differ from BALB/c mice in possessing  a small segment of 
chromosome 1 of DBA/2 mice containing the Bcg locus (13). All 
mice were free of common viral pathogens according to the re- 
sults of routine testing performed by the Research Animal Diag- 
nostic and Investigative Laboratory, University of Missouri, (Co- 
lumbia, MO). 
Mycobacteria.  M.  tuberculosis H37Rv  (TMC  #102)  was  ob- 
tained from the Trudeau Mycobacterial Culture (TMC) collection. 
It was supplied in vials as a frozen (-70~  log phase dispersed 
culture in Proskauer and Beck medium (Difco Laboratories Inc., 
Detroit, MI) containing 0.01% Tween 80.  For each experiment, 
a vial was thawed, subjected to 5 s of ultrasound to break up ag- 
gregates, and diluted appropriately  in PBS containing 0.01% Tween 
80. Mice were inoculated with "~10 s CFU of bacilli in 0.2 ml of 
PBS via a lateral tail vein, or with "5  ￿  102 CFU by aerosol. In- 
fection by aerosol was performed in a Middlebrook airborne in- 
fection  apparatus  (Tri  Instruments, Jamaica,  NY).  Bacilli were 
enumerated at progressive times in the lungs, kidneys, livers, and 
spleens of infected mice by preparing homogenates of these or- 
gans in PBS containing 0.05%  Tween 80 and plating 10-fold se- 
rial dilutions of the homogenates on enriched agar (Middlebrook 
7H11; Difco Laboratories Inc.). Colonies were enumerated after 
3-4 wk of incubation at 37~ 
Histology.  Pieces of lungs were taken at day 70 of infection 
and fixed in 10% phosphate-buffered formalin. The tissues were 
then dehydrated and wax embedded according to routine proce- 
dures.  Sections 4-6  ~m thick were stained with Ziehl Nielsen 
stain for acid-fast bacilli and counterstained with methylene blue. 
Photomicrographs were taken with a microscope (Microphot-Fx; 
Nikon Inc., Melville, NY). 
Results 
Bcg' Mice Are Much More Susceptible than Bc~ Mice to Mtb 
Infection Initiated  Intravenously  or by Aerosol.  In the first ex- 
periments,  DBA/2  (Bcg  9  and  MHC-compatible  BALB/c 
(Bcg  9 mice were infected with 10  s Mtb intravenously or with 
5  X  102  Mtb  by aerosol,  and  growth  of the  organism in 
lungs, livers, spleens, and kidneys was followed over a 100-d 
period.  Additional mice  were  infected  to  obtain  survival 
data. The results in Fig. 1 show that, in the case of infection 
via the intravenous route, Bcg  r mice were substantially less, 
rather than more, capable than Bcg  ~ mice of controlling the 
growth of Mtb in their lungs, in that the former mice had 
,'-~100 times more bacilli in this organ than the latter on day 
100 of infection. Both strains of mice were similar, on the 
other hand, in terms of their ability to stabilize infection in 
other organs. It can be seen with both strains of mice that, 
after a brief period of bacillary growth in the liver, spleen, 
and kidneys, infection was stabilized and caused to plateau 
until day 100. This superior resistance of BALB/c mice was 
independent of the size of inoculum.  Thus,  DBA/2  mice 
inoculated  intravenously  with  103  CFU  of Mtb  H37Rv 
contained 2.5 logs more bacilli in their lungs than BALB/c 
mice inoculated with the same number of bacteria (7.1  + 
0.3 log for DBA/2; 4.6  +  0.2 log for BALB/c) at day 80 of 
infection. 
In the case of infection initiated via the respiratory route 
(Fig. 2), Bcg  ~  mice were likewise less capable than Bcg  ~ mice 
of controlling Mtb  growth  in  their  lungs.  However,  Bcg  ~ 
mice  allowed much  less  initial seeding  of Mtb  from  the 
lungs to the liver and spleen. In spite of this, however, Mtb 
grew more  extensively in the livers of these mice than in 
the livers of Bcg  ~ mice a~er day 75 of infection. The smaller 
numbers of Mtb in the livers of DBA/2 mice on day 30 of 
the aerosol infection indicates that fewer organisms dissem- 
inated from the lungs to implant in the livers at this stage of 
infection. Presumably, similar levels of resistance were  ex- 
pressed in the livers of DBA/2 and BALB/c mice between 
days 30 and 70. The large increase in the number of Mtb in 
the livers of DBA/2 mice after day 70 might have resulted, 
at least in part, from continuous seeding of bacilli from the 
lungs, because of a massive increase in the number of bacilli 
in  this organ from  day 70  on.  It could also have  resulted 
from the expression of less resistance in the livers of DBA/ 
2 mice after day 70. 
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Figure 1.  Growth ofMtb H37Rv in Iungs, livers,  spleens,  and kidneys  of 
Beg' (DBA/2) and Bcg  ~  (BALB/c) mice inoculated intravenously with 2 ￿ 
105 organisms. Bcg  ~  mice were substantially  less resistant to Mtb infection, 
although only in the lungs. Means are for five mace per time point --- SD. 
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Figure  2.  Growth  of Mtb  in 
lungs,  livers and  spleens  of Bcg' 
(DBA/2)  and  /3cg' (BALB/c) 
mice given 5 ￿  102 Mtb via the 
respiratory route.  Bcg"  mice were 
much less resistant than Bcg'  mice 
in their lungs after day 20. In ad- 
dition,  Bcg' mice  showed  a 
smaller number of Mtb in their 
livers and spleens on day 20, al- 
though their livers were less ca- 
pable than  those  of Bcg' of con- 
trolling  infection  from  day  70 
on. Means are for five mice per 
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Figure 4.  Survival times of mice infected with Mtb aerosol as described 
for Fig. 3. Bcg'  (DBA/2) mice died much sooner (MST =  124 d) than Beg' 
(BALB/c) mice (MST =  303 d). There were 10 mice per group. 
BALB/c  mice  over Bco# DBA/2  mice  is  a  dominant  trait, 
growth of Mtb in the organs of these strains was compared 
with  its growth  in  their  F1  progeny  over a  100-d  period. 
As can be seen in Fig. 5, F1 mice were the same as BALB/c 
mice  in  displaying a  superior  ability  over DBA/2  mice  to 
resist  the  growth  of Mtb  in  their  lungs  after  inoculation 
with 10  s bacilli via the intravenous  route.  These results are 
supported  by  the  survival  data  in  Fig.  6  showing  that  F1 
and  BALB/c  mice  survived  more  than  twice  as  long  as 
DBA/2  mice from the 10S-bacilli intravenous inoculum. 
Resistance  to  Mtb  Infection  Is  Not  Determined  by  the  Bc,~ 
Gene,  The  foregoing results  show  that  mice  that  possess 
6  - 
even more convincingly demonstrated  by the survival data 
shown  in  Figs.  3  and  4.  It can be seen that  after initiating  ~>  4 
infection via either route,  the median survival time  (MST)  ~- 
of Bcg'  mice  was  substantially  shorter,  being less  than  half  :r 
that of Bcor mice.  ~  = 
Resistance  to Mtb Infection  Is a Dominant  Trait in F1 Mice.  o 
o  8 
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Figure 3.  Survival times of Bcg" (DBA/2) and/3cg  ~ (BALB/c) mice in- 
fected  intravenously  with Mtb  as  described  for Fig.  1.  Beg' mice died 
much sooner (MST =  84 d) than Bcg  ~  mice (MST =  290 d). There were 
10 mice in each group. 
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Figure S.  Growth of Mtb in lungs, livers, spleens, and kidneys of Bcg' 
(BALB/c),  Beg' (DBA/2) mice, and their F1 progeny (CD2-F1)  after in- 
travenous  inoculation  of 105 bacilli. CD2-F1  mice, like BALB/c mice, 
were substantially more resistant to Mtb growth in the lungs. Means are 
for five mice per time point +  SD. 
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Figure 6.  Evidence that CD2-F1 progeny of Bee (BALB/c) and Bcg' 
(DBA/2) mice, like BALB/c, were much more capable of surviving in- 
fection with Mtb. In this experiment, 10 mice per group were infected 
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Figure 8.  Survival  data of mice infected as described for Fig. 7. Bcor 
C.D2-N20-congenic  mice were more capable than Bog' DBA/2 mice of 
surviving infection. Results were obtained with 10 mice per group. 
the  resistance  allele of the  Bcg  gene  are  less,  rather  than 
more, resistant to infection with virulent Mtb, and that the 
F1 progeny of Bcg" and Bcg' mice are resistant like Bco~ mice. 
This could mean that the recessive Beg' allele is responsible 
for resistance  to  Mtb  and  that  it is dominant  when  mea- 
sured against Mtb in the F1. If so, it would follow that Bc~ 
BALB/c  mice  should be  more  resistant to  Mtb  infection 
r,~ 
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Figure 7.  Evidence that the su- 
perior  anti-Mtb  resistance of Bcg  ~ 
(BALB/c) mice over Beg" (DBA/2) 
mice  was  not  dependent  on  the 
presence of the Bc,( allele. Con- 
genic  C.D2-N20  BALB/c  mice 
possessing  a  small segment  of 
DBA/2  chromosome  1  contain- 
ing  the  Beg' locus  were,  like 
BALB/c mice, much more capable 
than  DBA/2  mice  of controlling 
Mtb infection in the lungs follow- 
ing intravenous inoculation of 2 ￿ 
10  s bacilli. Therefore, superior re- 
sistance of BALB/c mice depends 
on genes other than those in the 
Bcg locus. Means are for five mice 
per time point + SD. 
than  congenic  C.D2-N20  mice  that  differ from  BALB/c 
mice in possessing a small piece of chromosome 1 of DBA/2 
mice containing the Bcg  ~ gene. The results in Figs. 7  and 8 
show this not to be the case, in that Bcg'-congenic C.D2-N20 
mice,  like BALB/c  mice,  were  much  more  resistant than 
DBA/2 mice to Mtb infection, as measured by superior ca- 
pacifies to control Mtb growth in their lungs and to survive 
infection. It can be concluded from these results, therefore 
that  the presence  of the Bcor allele of the  Bcg gene  is not 
needed for BALB/c mice to be more resistant to Mtb in- 
fection than Bcor DBA/2 mice. In other words, resistance to 
Mtb infection is determined by genes other than the Beg gene. 
The Superior Anti-Mtb Resistance of BALB/c Mice Is Associ- 
ated with Slower Development of Lung Pathology.  It has been 
shown  in preceding sections that,  in spite of their posses- 
sion of the susceptibility  allele of the Beg gene, BALB/c mice 
are much more resistant to Mtb infection than DBA/2 mice 
that contain  the dominant resistance allele of the gene,  as 
measured by the ability of the former mice to restrict the 
growth  of Mtb  in  their lungs  and  survive  infection.  Be- 
cause the difference in anti-Mtb resistance was seen only in 
the lungs, it was anticipated that the longer survival time of 
Bcg' mice would be associated with the development of much 
less lung pathology. This prediction proved correct, as evi- 
denced by the photos of 20-1~m sections of lungs of  BALB/c 
and DBA/2 mice  (Fig. 9),  which show that on day 70  of 
infection the  lungs  of BALB/c  mice  displayed fewer  and 
smaller Mtb-induced lesions than the lungs of DBA/2 mice. 
At  higher  magnification,  the  lung  lesions  in  each  strain 
consisted of areas of intense alveolitis in which contiguous 
air sacs were  filled with  leukocytes,  most  of which  were 
mononuclear. Within each lesion, acid-fast bacilli were lo- 
cated in collections of epithelioid macrophages occupying 
contiguous air sacs. These sites of infection were larger and 
more numerous in lung lesions of DBA/2 mice (Fig. 9) and 
contained larger numbers of bacilli. A  histological examina- 
tion  of the livers and spleens of both  strains of mice  (not 
shown)  revealed that Mtb infection did not cause progres- 
sive pathology. Instead, stabilization of infection in these or- 
gans was associated with small compact granulomas that did 
not change in size or composition over time. This is in keep- 
ing with the results of another study in this laboratory (14). 
1048  Genetic Resistance to M. tuberculosis Figure 9.  Evidence that the superior ability of Bcg  ~ (BALB/c) mice over Bcg' (DBA/2) mice for controlling Mtb infection in their lungs was associated 
with substantially less pathology in this organ. On day 70 of infection initiated with 10  s Mtb via the intravenous route, there were fewer and smaller le- 
sions in 20-1~m crystal violet-stained sections of  lungs of  BALB/c mice (a) than in the lungs of  DBA/2 mice (b). In both cases, Mtb was confined to col- 
lections of epithelioid macrophages (arrows) that were more degenerate in lung lesions of DBA/2 mice (d) than in lung lesions of BALB/c mice (c). At 
higher power, these sites of  infection in DBA/2 mice (f) contained many more acid-fast bacilli than those in BALB/c mice (e). Samples were stained with 
Ziehl Nielsen counterstained with methylene blue. ￿  (a and b); ￿  (c and d); ￿  (e and  f). 
1049  Medina and North Discussion 
This study leaves little doubt that the dominant resistant 
allele  of the  Bcg gene  (Bcg'), which  is  responsible for the 
ability of certain strains of mice to better resist the growth of 
BCG and ce~ain other pathogens during the preimmunity 
stage of infection, has little or no influence on the ability of 
these strains to resist infection with virulent Mtb.  The re- 
sults  show  that  Bcg' DBA/2  mice  are  considerably  less, 
rather  than  more,  resistant  to  Mtb  infection  than  Bcg* 
BALB/c mice. This was the case with mice infected either 
via the respiratory or intravenous route. Superior anti-Mtb 
resistance of Bcg  ~  mice was measured as (a) a longer survival 
time, (b) a superior ability to control infection in the lung, 
and (c) slower development of lung pathology. Resistance 
to Mtb infection was a dominant trait in the F1 progeny of 
BALB/c and DBA/2 mice, which suggested the possibility 
that the Bcg  ~ rather than the Bcg" allele of the Bcg gene was 
responsible for resistance to Mtb. However, this proved not 
to be the  case,  as evidenced by the finding that Bcg'-con- 
genic  C.D2-N20  BALB/c  mice  were  like  Bcg  ~ BALB/c 
mice in being more resistant than Bcg' DBA/2 mice to in- 
fection with Mtb.  Because the recently isolated candidate 
gene for the Bcg gene, Nramp 1, is contained within the Bcg 
locus (8), it follows that Nrampl also has little, if any, influ- 
ence on resistance  to Mtb  infection,  at least according to 
the way that anti-Mtb resistance was measured in this study. 
It needs to be brought to mind, in this connection,  that 
the superior resistance of Bcg" mice to BCG infection has 
been measured almost exclusively in the spleen as a supe- 
rior ability to restrict the growth of  BCG during the preim- 
munity first 20 d of infection (15,  16).  On the other hand, 
it has been shown (17) that Bcg' and Bcg  ~ strains of mice are 
similar in  terms  of their  capacity to  restrict  preimmunity 
growth of BCG in other organs. Moreover, both types of 
mice seem equally capable of resolving BCG infection in 
all organs from 20 d of infection on, after specific immunity 
is  acquired.  Indeed,  being an  attenuated  organism,  BCG 
does not cause progressive disease  in any organ of suscepti- 
ble  or resistant  mice.  In  contrast,  Mtb  causes progressive 
disease  and kills both susceptible and resistant mice. How- 
ever, as shown here and elsewhere (14,  18), progressive dis- 
ease in mice is confined to the lungs. Therefore, tuberculo- 
sis  in  mice  is  similar to  tuberculosis  in  most humans,  in 
whom the disease is also confined to the lung (19),  in spite 
of hematogenous dissemination  of bacilli to other organs. 
The  results  presented  here  indicating  the  existence  of a 
gene(s) that makes some strains of mice more capable than 
others  of controlling the  growth  of virulent Mtb  in their 
lungs  and  consequently  of enabling  the  mice  to  survive 
longer from tuberculosis would seem more relevant to the 
human situation than a gene that influences the level of re- 
sistance against an attenuated organism only in the spleen. 
The  gene(s)  responsible  for  the  superior  resistance  of 
BALB/c mice to tuberculosis appears to have little relation- 
ship to the recessive Tbc-1 gene described some years ago 
(20)  that makes I/St mice more susceptible to Mtb infec- 
tion  than  A/Sn  mice.  It  is  almost  certain,  on  the  other 
hand, that MHC genes play a role in determining resistance 
of different  mouse  strains  to  tuberculosis,  although  pub- 
hshed .papers  dealing  with  this  subject  are  contradictory 
(21,  22). MHC genes were not a factor in the results pre- 
sented  here,  because  the  mouse  strains  used  are  MHC 
compatible. In fact, the strains included in this study have 
been used in most published studies of the genetic basis of 
anti-BCG resistance and for producing congenic strains pos- 
sessing the resistant DBA/2 Bcg locus of chromosome 1 (13). 
According to a number of in vitro studies (5, 7) the Bcg' 
allele of the Bcg gene makes macrophages of resistant mice 
innately more capable of restricting the  growth of myco- 
bacteria and of inactivating other microbial pathogens. Pre- 
sumably, in the  case of resistance to BCG,  however,  this 
would  not  apply to liver and lung macrophages, because 
resistance to BCG infection in these organs is the same in 
Bcg" and  Bcor mice.  Moreover,  it is apparent,  even in  the 
spleen, that the Bcg gene has a limited influence on the ulti- 
mate outcome of infection, in that innate differences in an- 
timicrobial  resistance  mechanisms  between  Bcg  r and  Bcg  s 
macrophages are eventually overridden by additional anti- 
microbial mechanisms acquired by these cells in response to 
specific immunity. Indeed, the capacity to generate specific 
immunity to BCG seems essentially  the same in Bcg"  and Bcg  ~ 
mice,  so far as  the  ability of mice  to  resolve infection  is 
concerned. However, this appears not to be the case for re- 
sistance to infection with Mtb,  as described here. Accord- 
ing to our results with BALB/c and DBA/2 mice infected 
with  the  same  number  of Mtb  via  the  respiratory  route 
(Fig. 3), the superior resistance of the former mice over the 
latter was seen in the lung after, rather than before, the on- 
set of expression of specific immunity,  as evidenced by a 
substantial reduction in the rate of Mtb growth in this or- 
gan from day 20 on. We are aware, however, that immu- 
nity  to  Mtb  infection  eventually is  expressed by macro- 
phages,  and  that  the  superior  resistance  of BALB/c  over 
DBA/2  mice to this pathogen may depend  on a superior 
ability ofBALB/c macrophages to acquire increased myco- 
bactericidal function  in  response to  cytokines secreted by 
Mtb-specific Tcells. 
Lastly,  it  needs  to  be  mentioned  that  virulence  of the 
H37Rv strain of Mtb for mice is similar to that of the re- 
cently isolated C  strain that is responsible for a larger num- 
ber of tuberculosis cases throughout the New York metro- 
politan area  (14).  On  the basis  of this  evidence,  it would 
seem reasonable to assume that H37Rv is still  virulent for 
humans, in spite of its having been isolated >60 yr ago. 
We acknowledge the expert technical assistance of Lynn Ryan, Debra Duso, and Ron LaCourse. 
1050  Genetic Resistance to M. tuberculosis This work was supported by grants HL-51960 and AI-37844 from the National Institutes of Health, and a 
general tuberculosis support grant from The G. Harold and Leila Y. Mathers Charitable Foundation. 
Address correspondence to Dr. Eva Medina, Trudeau Institute, P.O. Box 59, Saranac Lake, NY 12983. 
Received for publication  7 September  1995 and in revised  form  I November  1995. 
References 
1.  Skamene, E.,  P.  Gros, A.  Gorget, P.A.L. Kongshavn,  C.S. 
Charles, and B.A. Taylor. 1982.  Genetic regulation of resis- 
tance to intracellular pathogens. Nature (Lond.). 297:506-509. 
2.  Plant, J., and A.A. Glynn. 1979. Locating salmonella resistance 
gene on mouse chromosome 1. Clin. Exp. Immunol. 37:1-6. 
3.  Bradley, D.J.,  B.A. Taylor, J.  Blackwell, E.P.  Evans,  and J. 
Freeman. 1979.  l~egulation of Leishmania populations within 
the host. III. Mapping of the locus controlling susceptibility  to 
visceral leishmamasis in the mouse. Clin. Exp. Immunol. 37:7-14. 
4.  Schurr, E., E. Skamene, A. Forget, and P. Gros. 1989.  Link- 
age analysis of the Bcg gene on mouse chromosome 1: iden- 
tification of a tightly linked marker. J.  Immunol.  142:4507- 
4513. 
5.  Stach, J.L., P. Gros, A. Forget, and E. Skamene. 1984.  Phe- 
notypic expression of genetically controlled natural resistance 
to Mycobacterium boris (BCG).J. Immunol. 132:888-892. 
6.  Lissner, C.R., R.N. Swanson, and A.D. O'Brien. 1983.  Ge- 
netic control of the innate resistance of mice to Salmonella ty- 
phimurium: expression of the Ity gene in peritoneal and splenic 
macrophages isolated in vitro.  J. Immunol. 131:3006-3013. 
7.  Olivier, M., and C.E. Tanner.  1987.  Susceptibilities of mac- 
rophage populations to infection in vitro by Leishmania dono- 
vani. Infect. Immun.  55:467-471. 
8.  Vidal, S.M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 
1993.  Natural resistance to infection with intracellular para- 
sites: identification of  a candidate gene for Bcg. Cell. 73:469--485. 
9.  Gruenheid, S., M. Cellier, S. Vidal, and P. Gros. 1995.  Iden- 
tification  and  characterization  of a  second  mouse  Nramp 
gene. Genomics. 25:514-525. 
10. Malo, D., K. Vogan, S. Vidal, J. Hu, M.  Cellier, E. Schurr, 
A. Fuks, N. Bumstead, K. Morgan, and P. Gros. 1994.  Hap- 
lotype mapping and sequence analysis  of the mouse Nramp 
gene predicts susceptibility  to infection with intracellular par- 
asites. Genomics. 23:51-61. 
11. Vidal, S., M.L. Tremblay, G. Govoni, S. Gauthier, G. Sebas- 
tiani, D.  Malo,  E.  Skamene,  M.  Olivier,  S, Jothy,  and P. 
Gros.  1995.  The Ity/Lsh/Bcg locus: natural resistance to in- 
fection with intracellular parasites is abrogated by disruption 
of the Nrampl gene.J. Exp. Med.  182:655-666. 
12. CeUier, M.,  G.  Govoni, S.  Vidal, T.  Kwan,  N.  Groulx, J. 
Liu, F. Sanchez, E. Skamene, E. Schurr, and P. Gros. 1994. 
Human  natural  resistance-associated  macrophage  protein: 
cDNA  cloning,  chromosomal mapping,  genomic  organiza- 
tion, and tissue-specific expression. J.  Exp.  Med.  180:1741- 
1752. 
13. Mock, B.A., D.L. Holiday, D.P. Cerretti, S.C. Damell, A.D. 
O'Brien, and M. Potter. 1994. Construction of a series ofcon- 
genic  mice  with  recombinant  chromosome  1  regions sur- 
rounding the genetic loci for resistance to intracellular para- 
sites (Ity, Lsh,  and Bcg), DNA repair responses ([kep-1), and 
the cytoskeletal protein viUin (Vil). Infect. Immun. 62:325--328. 
14. Dunn,  P.L.,  and  R.J.  North.  1995.  Virulence  ranking  of 
some Mycobacterium tuberculosis and Mycobacterium bovis strains 
according to  their ability to  multiply in  the  lungs,  induce 
lung pathology, and cause mortality in mice. Infect. Immun. 
63:3428-3437. 
15. Skamene, E. 1989.  Genetic control of susceptibility to myco- 
bacterial infections. Rev. Infect. Dis.  11:394-399. 
16. Buschman,  E.,  A.S.  Apt, B.V.  Nickonenko,  A.M.  Moroz, 
M.H. Averbakh, and E.  Skamene.  1988.  Genetic aspects of 
innate resistance and acquired immunity to mycobacteria in 
inbred mice. Springer Semin. Immunopathol. 10:319-336. 
17. Orme,  I.M., and F.M. Collins. 1984.  Demonstration of ac- 
quired resistance in Bcg  ~ inbred mouse strains infected with a 
low dose of BCG Montreal. Clin. Exp. Immunol. 56:81-88. 
18. North,  R.J.,  and A.A. Izzo.  1993.  Mycobacterial virulence. 
virulent strains of Mycobacteria tuberculosis have faster in vivo 
doubling times and are better equipped to resistant growth- 
inhibiting functions of macrophages in the presence and ab- 
sence of specific immunity.J. Exp. Med.  177:1723-1733. 
19. Hopewell, P.C.  1994.  Overview of clinical tuberculosis. In 
Tuberculosis:  Pathogenesis,  Protection  and  Control.  B.R. 
Bloom, editor. ASM Press, Washington, DC. 25-46. 
20. Buschman,  E.,  A.S.  Apt,  B.V.  Nickonenko,  A.M.  Moroz, 
M.H.  Averbakh, and E. Skamene.  1988.  Genetic aspects of 
innate resistance and acquired immunity to Mycobacteria in in- 
bred mice. Springer Semin. Immunopathol. 10:319-336. 
21. Brett, S., J.M. Orrell, J.  Swanson Beck, and J. Ivanyi. 1992. 
Influence of H-2 genes on growth of Mycobacterium tuberculo- 
sis in the lungs of chronically infected mice. Immunology. 76: 
129-132. 
22. Apt, A.S., V.G. Avdienko, B.V.  Nikonenko, I.B. Kramnik, 
A.M. Moroz, and E. Skamene. 1993.  Distinct H-2 complex 
control of mortality, and immune  responses to  tuberculosis 
infection in virgin and BCG-vaccinated mice. Clin. Exp. Im- 
munol. 94:322-329. 
1051  Medina and North 